Boston Scientific (BSX) PT Raised to $48 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St futures up as oil slips; telecoms pressured by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- UBS flags level in gold prices where dip buyers will likely emerge
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- Investors need sustained Fed cuts to move cash off sidelines: BofA's Hartnett
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $42.04 --0%
Rating Summary:
31 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 28
Rating Summary:
31 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 28
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Boston Scientific (NYSE: BSX) to $48.00 (from $45.00) while maintaining a Buy rating.
You May Also Be Interested In
- Barclays Starts Boston Scientific (BSX) at Equalweight
- Zeta Global Holdings Corp (ZETA) PT Raised to $38 at B.Riley
- Realty Income (O) PT Lowered to $63.75 at Stifel Amid Rising Rates
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
